The experimental drug lecanemab shows potential as an Alzheimers disease treatment, according to new Phase 3 trial results, but the findings raise some safety concerns because of its association with… [read more]
Experimental drug appears to slow progression of Alzheimer’s disease in clinical trial but raises safety concerns – CNN
You Might Also Like
How a failed Tumblr convention became one of the most important social media lessons of the 2010s – CNN
DCLA’s Sarat Sethi on Nvidia: Great company but valuation ‘a little stretched’ – CNBC Television
